Assaf C. Bester
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- DNA Repair Mechanisms 7
- RNA modifications and cancer 4
- CRISPR and Genetic Engineering 2
-
- Cancer-related molecular mechanisms research 6
- Cancer Genomics and Diagnostics 1
- Co-authors
- Batsheva Kerem (10 shared papers)Aaron Bensimon (2 shared papers)Yifat S. Oren (3 shared papers)Donna S. Shewach (2 shared papers)Michael M. Im (2 shared papers)Dan Sarni (1 shared paper)Maayan Roniger (1 shared paper)Gideon Zamir (1 shared paper)
- Journals
- Cell (2 papers)EMBO Molecular Medicine (2 papers)Scientific Reports (2 papers)Molecular Cell (1 paper)Journal of Biomedical Science (1 paper)
- Partner nations
- IsraelUnited StatesFrance
In The Last Decade
Assaf C. Bester
16 papers receiving 1.4k citations
Assaf C. Bester's Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 341
- Molecular Biology 1.2k
- Cell Biology 181
- Aging 19
- Oncology 268
Countries citing papers authored by Assaf C. Bester
This map shows the geographic impact of Assaf C. Bester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assaf C. Bester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assaf C. Bester more than expected).
Fields of papers citing papers by Assaf C. Bester
This network shows the impact of papers produced by Assaf C. Bester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assaf C. Bester. The network helps show where Assaf C. Bester may publish in the future.
Co-authors
The 25 scholars most cited alongside Assaf C. Bester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development Hit paper breakdown → | 2011 | 643 |
| 2 | 2018 | 240 | |
| 3 | 2011 | 137 | |
| 4 | 2020 | 74 | |
| 5 | 2012 | 68 | |
| 6 | 2006 | 40 | |
| 7 | 2014 | 31 | |
| 8 | 2015 | 28 | |
| 9 | 2014 | 24 | |
| 10 | 2014 | 18 | |
| 11 | 2017 | 17 | |
| 12 | 2009 | 16 | |
| 13 | 2021 | 14 | |
| 14 | 2013 | 8 | |
| 15 | 2024 | 5 | |
| 16 | 2025 | 2 |
About Assaf C. Bester
Assaf C. Bester is a scholar working on Molecular Biology, Cancer Research, Genetics, Epidemiology and Pathology and Forensic Medicine, having authored 16 papers that have together received 1.4k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (7 papers), Cancer-related molecular mechanisms research (6 papers), Genetics and Neurodevelopmental Disorders (5 papers), RNA modifications and cancer (4 papers), Cytomegalovirus and herpesvirus research (2 papers), CRISPR and Genetic Engineering (2 papers), Folate and B Vitamins Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (341 citations), Molecular Biology (1.2k citations), Cell Biology (181 citations), Aging (19 citations) and Oncology (268 citations). Assaf C. Bester has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Batsheva Kerem, Aaron Bensimon, Yifat S. Oren, Donna S. Shewach, Michael M. Im, Dan Sarni, Maayan Roniger, Gideon Zamir, E. Ozeri-Galai and Ayelet Rahat. Their work appears in journals such as Cell, EMBO Molecular Medicine, Scientific Reports, Molecular Cell and Journal of Biomedical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.